Regional Human Capital Operations Manager – Human Capital x2 (Harare)

SAP Support Analyst (F1) – ICT: LEVEL 9 (Harare)

ABAP Developer: Level 9 (Harare)

Procurement Manager: D5 (Harare)

Financial Accountant (Harare)

Sales Consultant (Kadoma)

Cervical Cancer & Clinical Service Mentor Nurse

Laboratory Technician (Harare)

Spport Driver (Harare)

Food Security and Livelihoods Head of Department (Harare)

Accountant (Harare)

Accounting Assistants x3 (Harare)

Communications Intern (Harare)

Corporate Legal Counsel (Kamativi)

Company Secretary (Harare)

Marketing Manager (Harare)

Sales Manager (Harare)

Procurement Manager (D5)

Director Policy and Market Development (Harare)

Assistant Valuer Grade 7

Town Planner Grade 10

Till Operator x2 (Bindura)

Ambulance Technician (Bindura)

Business Development Manager

Intellectual Property Manager

Chief Research Officer (Bindura)

Teaching Assistant: Banking and Finance (Bindura)

Technical Assistant: Natural Resource Management (Bindura)

Administrator (Bindura)

Faculties Manager (Harare)

Staff Development Fellow: Department of Veterinary Pathobiology x4 (Harare)

Staff Development Fellow: Department of Construction & Civil Engineering (Harare)

Officer: Student Residential and Logistical Services (Harare)

Student Development Officers (Harare)

Information Manager (Harare)

Graphic Designer x2 (Harare)

Marketing Officer (Harare)

Technical/Copy Editor x2 (Harare)

Proofreader x2 (Harare)

Typesetter x2 (Harare)

Acquisitions Editors x2 (Harare)

General Hand (Harare)

Locum Pharmacists (Mutare & Ngezi)

Drivers x2 (Harare Campus)

Graphic Designer (Gweru)

Drivers (Harare Campus)

Artisan Supervisor – Fleet Maintenance (Gweru)

Transport and Logistics Officer - Tracking (Gweru)

SHEQ Intern/ Attaché (Bulawayo)

Nutrition Officer (Mutare)

Team Leader (Mutare)

Project Field Officer (Mutare)

Monitoring and Evaluation Officer (Mutare)

Assistant Accountant-Retail (Harare)

Trainee Risk Officer (Harare)

Sales Manager (Bulawayo)

Zimbabwean scientists have announced a potential breakthrough in the treatment of Alzheimer’s disease and melanoma, a type of skin cancer, reported <a href="https://www.zimlive.com/zimbabwean-scientists-claim-discovery-of-alzheimers-melanoma-cancer-cure/">ZimLive</a>.
Alzheimer’s is a progressive neurological disorder that primarily impacts memory, thinking, and behavior, and is the leading cause of dementia.
Professor Simon Mukwembi, the lead scientist on the project, stated that through a computer system, they have named Rutava, researchers identified a chemical compound that specifically targets malignant cancer cells without affecting healthy cells in the body.
This research was conducted in collaboration with the University of Witwatersrand and the University of Johannesburg in South Africa.
At a news conference in Harare on Thursday, Professor Mukwembi said that the study focused exclusively on treatments for melanoma and Alzheimer’s disease. He said:
<blockquote>
The good thing that Rutava does is you can recalibrate it for other diseases. So, for the cancer, we’ve got quite a number of cancers, right?
What we have worked on right now is melanoma skin cancer. But of course, we can extend out to sort out all the other cancers without difficulty because we now have the innovative technology.
… We also developed, using the Rutava, a cure for Alzheimer’s disease.
</blockquote>
Professor Mukwembi described Rutava as a “digital technology powered by artificial intelligence, machine learning, and advanced mathematical formulas.”
He explained that this innovative technology has the potential to significantly reduce the time required to transition from discovery to drug development, shortening the process from several years to just a few months. He added:
<blockquote>
I’m pleased to say we used Rutava to discover drugs for the treatment of different diseases. First, there is cancer. We’ve got a compound that can target only cancerous cells in the human body.
Currently, the difficulty is that the available cancer drugs target both the cancerous cells and the healthy normal cells. Rutava only targets the cancerous cells.
About 10 million people died of cancer in 2020 and the same number in 2023. So you can see the market for the cancer drug is huge the world over.
</blockquote>
Prof Mukwembi, who is the chairman of the Harare Institute of Public Health (HIPH), was flanked by the institute’s principal Dr Amos Marume and its registrar Dr Isaac Mutingwende.
He expressed confidence that their technology could potentially cure cancer and Alzheimer’s disease but emphasized the need to conduct clinical trials to validate their findings.
Other scientists involved in the project include Dr Eloise van der Merwe, Professor Farai Nyabadza, Professor Yasien Sayed, Professor Betsie Jonck, Professor Eunice Mphako-Banda, Dr Ronnie Maartens, Moster Zhangazha, Neo Padi, and Thabelo Mulenga.
Dr Marume stated that although their discovery will be patented, their share of future profits may be diluted due to the need for funding to develop the drugs and treatments.
More: <a href="https://www.pindula.co.zw/">Pindula News</a>

Pindula News

Zimbabwean scientists say they found ways to treat Alzheimer's and melanoma cancer. They used a computer system to identify a chemical that targets cancer cells without hurting healthy ones. This was done with help from South African universities. The technology they used can speed up drug development and focus only on cancer cells. They want to do more research and clinical trials to confirm their findings. If successful, this could be a big breakthrough for treating cancer and Alzheimer's.

Zimbabwean Scientists Claim Discovery Of Alzheimer’s, Melanoma Cancer Treatment

Cancer Latest News

Latest Jobs